Otezla

NDC 55513-485, apremilast, kit, from Amgen, Inc.

Product NDC: 55513-485
Status: Listed
Labeler: Amgen, Inc
Dosage form: KIT
Route: —
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: NDA
Application: NDA205437
DEA schedule: None

Request

curl https://api.healthcare.dev/v1/drugs/ndc/55513-485 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDC	NDC-11	Package
55513-485-96	55513048596	5 BLISTER PACK in 1 CARTON (55513-485-96) / 1 KIT in 1 BLISTER PACK (55513-485-95)

Linked data

RxNorm, label and prices

RxNorm concepts

1492748{4 (apremilast 10 MG Oral Tablet [Otezla]) / 4 (apremilast 20 MG Oral Tablet [Otezla]) / 19 (apremilast 30 MG Oral Tablet [Otezla]) } Pack [Otezla 14-Day 10/20/30 Starter Pack] (BPCK)

Related lookups

FDA label sections
GET /v1/drugs/labels/f6b1f516-4972-4d82-bced-113e47b41cc5

Use it

Look up 55513-485 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/ndc/55513-485 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up NDC 55513-485. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Get a free key NDC docs Connect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.